Prediction of the response of colorectal cancer to systemic therapy-Reference-Cited by-同舟云学术

Prediction of the response of colorectal cancer to systemic therapy

Published:2002-02 Issue:2 Volume:3 Page:75-82
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Adlard Julian W,Richman Susan D,Seymour Matthew T,Quirke Phil

Publisher

Elsevier BV

Subject

Oncology

Reference60 articles.

1. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage Ill colon carcinoma: a final report;Moertel;Ann Intern Med,1995

2. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer;International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators;Lancet,1995

3. Preliminary results of a multicentre randomised trial comparing three chemotherapy regimens (De Gramont, Lokich and Raltitrexed) in metastatic colorectal cancer;Ledermann;Br J Cancer,1999

4. Irinotecan in the treatment of colorectal cancer: clinical overview;Vanhoefer;J Clin Oncol,2001

5. Oxaliplatin: a new agent for colorectal cancer;Pelley;Curr Oncol Rep,2001

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation;Cancer Immunology, Immunotherapy;2023-03-07

2. Molecular mechanisms associated with chemoresistance in esophageal cancer;Cellular and Molecular Life Sciences;2022-02

3. Cedrol restricts the growth of colorectal cancer in vitro and in vivo by inducing cell cycle arrest and caspase-dependent apoptotic cell death;International Journal of Medical Sciences;2022

4. Regulatory role of the transforming growth factor-β signaling pathway in the drug resistance of gastrointestinal cancers;World Journal of Gastrointestinal Oncology;2021-11-15

5. ATAD3A stabilizes GRP78 to suppress ER stress for acquired chemoresistance in colorectal cancer;Journal of Cellular Physiology;2021-02-12